Article Details

Buy Rating Affirmed for Vor Biopharma Amid Promising Clinical Trials and Market Potential ...

Retrieved on: 2024-05-15 19:39:50

Tags for this article:

Click the tags to see associated articles and topics

Buy Rating Affirmed for Vor Biopharma Amid Promising Clinical Trials and Market Potential .... View article details on hiswai:

Excerpt

Justin Walsh, an analyst from JonesTrading, reiterated the Buy rating on Vor Biopharma (VOR – Research Report). The associated price targe...

Article found on: markets.businessinsider.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo